Navigation Links
Scientists confirm that the Justinianic Plague was caused by the bacterium Yersinia pestis

From the several pandemics generally called 'pestilences' three are historically recognized as due to plague, but only for the third pandemic of the 19th to 21st centuries AD there were microbiological evidences that the causing agent was the bacterium Yersinia pestis. "For a long time scholars from different disciplines have intensively discussed about the actual etiological agents of the past pandemics. Only ancient DNA analyses carried out on skeletal remains of plague victims could finally conclude the debate", said Dr. Barbara Bramanti of the Palaeogenetics Group at the Institute of Anthropology at Johannes Gutenberg University Mainz (JGU). About two years ago, she headed the international team which demonstrated beyond any doubt that Y. pestis also caused the second pandemic of the 14th-17th centuries including the Black Death, the infamous epidemic that ravaged Europe from 1346 to 1351. Bramanti and her Mainz colleague Stephanie Hnsch now cooperated with the University of Munich, the German Bundeswehr, and international scholars to solve the debate as to whether Y. pestis caused the so-called Justinianic Plague of the 6th to 8th centuries AD. The results of ancient DNA analyses carried out on the early medieval cemetery of Aschheim in Bavaria were published last week in PloS Pathogens. They confirmed unambiguously that Y. pestis was indeed the causing agent of the first pandemic, in contrast to what has been postulated by other scientists recently. This revolutionary result is supported by the analysis of the genotype of the ancient strain which provide information about the phylogeny and the place of origin of this plague. As for the second and third pandemic, the original sources of the plague bacillus were in Asia.

"It remains questionable whether at the time of the Byzantine Emperor Justinian only one strain or more were disseminated in Europe, as it was at the time of the Black Death," suggested Bramanti and Hnsch. To further investigate this and other open questions about the modalities and route of transmission of the medieval plagues, Bramanti has recently obtained an ERC Advanced Grant for the project "The medieval plagues: ecology, transmission modalities and routes of the infection" (MedPlag) and will move to the Center for Ecological and Evolutionary Synthesis (CEES) at the University of Oslo in Norway. The CEES, chaired by Nils Chr. Stenseth, has an outstanding and rewarded record of excellence in the research on infectious diseases and in particular on Y. pestis. The MedPlag research group is constituted by Stephanie Hnsch, Lars Walloe, Boris Schmid, Kyrre L. Kausrud and Ryan W. Easterday (University of Oslo, Norway), Mark Achtman (University of Warwick, UK), Elisabeth Carniel (Institute Pasteur, Paris, France), Raffaella Bianucci (University of Turin, Italy), Ulf Bntgen (Swiss Federal Research Institute for Forest, Snow and Landscape, Switzerland) as well as celebrated historians and archaeologists from Europe, Asia, and America.


Contact: Dr. Barbara Bramanti
Johannes Gutenberg Universitaet Mainz

Related biology news :

1. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
2. Queens scientists seek vaccine for Pseudomonas infection
3. Scientists produce eye structures from human blood-derived stem cells
4. American Society of Plant Biologists honors early career women scientists
5. Brandeis scientists win prestigious prize for circadian rhythms research
6. Scientists discover new method of proton transfer
7. Salk scientists open new window into how cancers override cellular growth controls
8. - Now Featuring Bespoke Pages for China’s Life Scientists
9. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
10. UGA scientists reveal genetic mutation depicted in van Goghs sunflower paintings
11. Genetic mutation depicted in van Goghs sunflower paintings revealed by scientists
Post Your Comments:
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... STACS DNA Inc., ... Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field ... DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: